AAAAAA

   
Results: 1-10 |
Results: 10
A phase I trial of carboxyamido-triazole and paclitaxel for relapsed solidtumors: Potential efficacy of the combination and demonstration of pharmacokinetic interaction
Authors: Kohn, EC Reed, E Sarosy, GA Minasian, L Bauer, KS Bostick-Bruton, F Kulpa, V Fuse, E Tompkins, A Noone, M Goldspiel, B Pluda, J Figg, WD Liotta, LA
Citation: Ec. Kohn et al., A phase I trial of carboxyamido-triazole and paclitaxel for relapsed solidtumors: Potential efficacy of the combination and demonstration of pharmacokinetic interaction, CLIN CANC R, 7(6), 2001, pp. 1600-1609
Phase I trial of 72-hour continuous infusion UCN-01 in patients with refractory neoplasms
Authors: Sausville, EA Arbuck, SG Messmann, R Headlee, D Bauer, KS Lush, RM Murgo, A Figg, WD Lahusen, T Jaken, S Jing, XX Roberge, M Fuse, E Kuwabara, T Senderowicz, AM
Citation: Ea. Sausville et al., Phase I trial of 72-hour continuous infusion UCN-01 in patients with refractory neoplasms, J CL ONCOL, 19(8), 2001, pp. 2319-2333
High-performance liquid chromatography with mass spectrometry detection for quantitating COL-3, a chemically modified tetracycline, in human plasma
Authors: Rudek, MA March, CL Bauer, KS Pluda, JM Figg, WD
Citation: Ma. Rudek et al., High-performance liquid chromatography with mass spectrometry detection for quantitating COL-3, a chemically modified tetracycline, in human plasma, J PHARM B, 22(6), 2000, pp. 1003-1014
A high-performance liquid chromatography method using ultraviolet and fluorescence detection for the quantitation of UCN-01, 7-hydroxystaurosporine, from human plasma and saliva
Authors: Bauer, KS Lush, RM Rudek, MA Shih, C Sausville, E Figg, WD
Citation: Ks. Bauer et al., A high-performance liquid chromatography method using ultraviolet and fluorescence detection for the quantitation of UCN-01, 7-hydroxystaurosporine, from human plasma and saliva, BIOMED CHRO, 14(5), 2000, pp. 338-343
Carboxyamido-triazole inhibits angiogenesis by blocking the calcium-mediated nitric-oxide synthase-vascular endothelial growth factor pathway
Authors: Bauer, KS Cude, KJ Dixon, SC Kruger, EA Figg, WD
Citation: Ks. Bauer et al., Carboxyamido-triazole inhibits angiogenesis by blocking the calcium-mediated nitric-oxide synthase-vascular endothelial growth factor pathway, J PHARM EXP, 292(1), 2000, pp. 31-37
A pharmacokinetically guided phase II study of carboxyamido-triazole in androgen-independent prostate cancer
Authors: Bauer, KS Figg, WD Hamilton, JM Jones, EC Premkumar, A Steinberg, SM Dyer, V Linehan, WM Pluda, JM Reed, E
Citation: Ks. Bauer et al., A pharmacokinetically guided phase II study of carboxyamido-triazole in androgen-independent prostate cancer, CLIN CANC R, 5(9), 1999, pp. 2324-2329
Thalidomide up-regulates prostate-specific antigen secretion from LNCaP cells
Authors: Dixon, SC Kruger, EA Bauer, KS Figg, WD
Citation: Sc. Dixon et al., Thalidomide up-regulates prostate-specific antigen secretion from LNCaP cells, CANC CHEMOT, 43, 1999, pp. S78-S84
Pharmacokinetics of cisplatin administered by continuous hyperthermic peritoneal perfusion (CHPP) to patients with peritoneal carcinomatosis
Authors: Cho, HK Lush, RM Bartlett, DL Alexander, HR Wu, PC Libutti, SK Lee, KB Venzon, DJ Bauer, KS Reed, E Figg, WD
Citation: Hk. Cho et al., Pharmacokinetics of cisplatin administered by continuous hyperthermic peritoneal perfusion (CHPP) to patients with peritoneal carcinomatosis, J CLIN PHAR, 39(4), 1999, pp. 394-401
Pharmacokinetics of thalidomide in an elderly prostate cancer population
Authors: Figg, WD Raje, S Bauer, KS Tompkins, A Venzon, D Bergan, R Chen, A Hamilton, M Pluda, J Reed, E
Citation: Wd. Figg et al., Pharmacokinetics of thalidomide in an elderly prostate cancer population, J PHARM SCI, 88(1), 1999, pp. 121-125
Pharmacokinetics and relative bioavailability of carboxyamido-triazole with respect to food and time of administration: Use of a single model for simultaneous determination of changing parameters
Authors: Bauer, KS Kohn, EC Lush, RM Steinberg, SM Davis, P Kohler, D Reed, E Figg, WD
Citation: Ks. Bauer et al., Pharmacokinetics and relative bioavailability of carboxyamido-triazole with respect to food and time of administration: Use of a single model for simultaneous determination of changing parameters, J PHAR BIOP, 26(6), 1998, pp. 673-687
Risultati: 1-10 |